Oesophageal Crohn's disease: A novel approach to managing iatrogenic perforation of an oesophageal Crohn's stricture.

摘要

Dear Sir, The prevalence of oesophageal Crohn's disease (CD) is 0.3-2%. Management is with corticosteroids, 5-aminosalicylic acids, immunomodulators or biologies as for active CD elsewhere plus acid suppression with proton pump inhibitors or H_2-receptor antagonists. Strictures are additionally treated with repeated dilatations. Surgery for strictures is reserved as a final option, because of the associated risk of operative morbidity as well as local recurrence. Spontaneous perforation and local fistula formation are reported, typically requiring surgery.